Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapyMaria Vittoria Dieci, PierFranco Conte, Vassilena Tsvetkova et al.|European Journal of Cancer|2020Cited by 74
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III DiseaseMaria Vittoria Dieci, Valentina Guarneri, Cristina Falci et al.|Frontiers in Oncology|2019Cited by 71
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Valentina Guarneri, Maria Vittoria Dieci et al.|The Oncologist|2020Cited by 16
Neoplastic Pericardial Effusion: A Monocentric Retrospective StudyElisabetta Di Liso, PierFranco Conte, Alice Menichetti et al.|Journal of Palliative Medicine|2019Cited by 11
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Valentina Guarneri, Luisa Carbognin et al.|British Journal of Cancer|2022Cited by 9